Why It's Important to Continue to Develop New Antifungals
MAY 11, 2019 | CONTAGION® EDITORIAL STAFF
Segment Description: Minh-Hong Nguyen, MD, professor of medicine at the University of Pittsburgh, explains why it's so important to continue developing new antifungal drugs.
Interview transcript (modified slightly for readability):
Contagion®: Why is it so important to continue to develop new antifungal drugs?
Dr. Nguyen: Just like bacteria, the more we use of a drug, the chance for the organism to develop resistance is very high. For example, among the Candida species beside Candida glabrata, we now see Candida auris infect a lot of patients throughout the US. The problem with Candida auris is that it tends to be multidrug-resistant, including echinocandin-resistant so the discovery of new drugs really, really helps in the management of our patients.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512